Treatment of early--stages I and II--nodular, poorly differentiated XXXX .

@entity1 @entity137 @entity1072 @entity706
Twenty-nine @entity1 with Stages I and II nodular, poorly differentiated @entity1072 were treated with radiation therapy or radiation therapy plus chemotherapy. Twenty-two @entity1 with Stage I received radiation to the involved field, the other seven with Stage II received total lymphoid radiation. Complete remission was achieved in all 29. There were no differences in remission duration or survival according to treatment modality. Five of 29 (17%) @entity1 relapsed. No relapses were observed after 5 years. Ten @entity1 died; one @entity1 died of @entity706 , and nine others died in continuous complete remission of various other causes. Sixty-six percent of the @entity1 were alive at 74-160 months (median 118 months). Involved field radiation with or without chemotherapy was well tolerated, producing acceptable @entity137 . Substantially more @entity137 was observed after total lymphoid irradiation and although cures were also achieved, less toxic treatment programs should be investigated. The low rate of relapse observed in early stages of this @entity706 in this and in other studies is suggestive that cures might be achieved in nearly one-half of the @entity1 presenting in early stage.
